In addition, PDLIM2 dysregulation is also closely related to several human cancers (e.g., hepatocellular carcinoma), and is associated with poor prognosis of patients, making it a potentially effective target for other cancer types as well (Figure 1) (Lv et al., 2023). This evidence concerns the gene PDLIM2 and cancer.